The current trend in the pharmaceutical industry for the manufacture of small-molecule therapeutic agents is moving toward continuous flow processes. This article is part of a special issue on APIs.
Fueled by a need to reduce costs and improve efficiencies, continuous processing may be the next paradigm shift in pharmaceutical manufacturing. Although common in other process manufacturing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback